A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression - Wikidata - awgldk - TriplyDB

A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression

A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression

http://www.wikidata.org/entity/Q34224640

about

Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells.Emerging roles of PDGF-D in EMT progression during tumorigenesis A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients.Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression Emerging roles of PDGF-D signaling pathway in tumor development and progression.Targeting the PDGF signaling pathway in tumor treatment Maternal transmission effect of a PDGF-C SNP on nonsyndromic cleft lip with or without palate from a Chinese population A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis.Prostate-specific antigen modulates the expression of genes involved in prostate tumor growth miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer.Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial.Dynamic regulation of platelet-derived growth factor D (PDGF-D) activity and extracellular spatial distribution by matriptase-mediated proteolysis.PTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancer Cediranib inhibits both the intraosseous growth of PDGF D-positive prostate cancer cells and the associated bone reaction Cyclic RGD-targeting of reversibly stabilized DNA nanoparticles enhances cell uptake and transfection in vitro.A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth Functional malignant cell heterogeneity in pancreatic neuroendocrine tumors revealed by targeting of PDGF-DD A critical role of the PTEN/PDGF signaling network for the regulation of radiosensitivity in adenocarcinoma of the prostate.Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells Matriptase activation and shedding through PDGF-D-mediated extracellular acidosis.MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.Differential tumorigenic potential and matriptase activation between PDGF B versus PDGF D in prostate cancer.The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer.Tyrosine kinase inhibitors in the treatment of prostate cancer: taking the next step in clinical development.Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics.Convergence of eicosanoid and integrin biology: Role of Src in 12-LOX activation.The interaction between androgen receptor and PDGF-D in the radiation response of prostate carcinoma.Targeting the vasculature: anti-angiogenic agents for malignant mesothelioma.Gastric cancer-derived MSC-secreted PDGF-DD promotes gastric cancer progression.Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.Down-regulation of platelet-derived growth factor-D expression blockades NF-κB pathway to inhibit cell proliferation and invasion as well as induce apoptosis in esophageal squamous cell carcinoma.PDGF-D/PDGF-ββ receptor-regulated chemotaxis of malignant mesothelioma cells.Evidence for cell density affecting C2C12 myogenesis: possible regulation of myogenesis by cell-cell communication.Inhibitory effect of soluble platelet-derived growth factor receptor β on intraosseous growth of breast cancer cells in nude mice.Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-κB.Clinical significance of platelet derived growth factor-C and -D in gastric cancer.

P2860

Q24531982-3470DD17-6F6D-47C8-A865-B30C3719C204 Q26859634-A46F1B53-F6F2-4FB1-8466-A4EEF2B4D660 Q33415009-8063D4A0-4DEA-44C3-A71C-BA4A1C7EAE75 Q33866927-36B90485-0008-419B-AEA5-D40A78F4616F Q33912608-6E2FD51B-8741-4ED0-B9E7-D6F5F41A24EA Q34393461-D31ECEA6-42AA-4A2B-B9F0-37AB6CD30308 Q34431283-C477507B-AEE1-4689-A4E8-4BBC0298FCC4 Q34683885-67629E36-9F94-4442-B385-27635F5AB4F3 Q34699785-9D026099-E1A1-4297-AAC6-30483CFDC1FF Q34768349-DFB458ED-C535-4501-8911-ADFF99111FE9 Q34988143-0EF43AF0-E877-4CA2-8BAB-6BB8CC787DFF Q35024076-03FD613F-9D11-40D3-84C6-A77CA2DCEF6D Q35555303-69F16E76-3BC1-40A3-8F9D-5C023EFFF919 Q35580879-54473EFA-7206-4B3F-BA02-E64E8E6C9B2F Q35952035-E562D9C7-ADE6-441B-8327-07E5C15CFEF3 Q36013452-504A7F7F-882A-4FB8-975C-AFAFF5AADDAC Q36306814-3385CF46-D825-480B-81C1-89ED75B35BC2 Q36352562-FB0AFA2F-F6EE-43B9-BD1A-9C777941072B Q36607541-62976898-321D-4F35-9B31-2ED88D2526E2 Q37035984-CB0C067F-D776-4822-B340-A9781CF7B93D Q37132900-FD15C25E-D7A2-448F-A876-C2A5BB1EA537 Q37154190-54D705CA-BE18-4739-BD2C-D1678A5A5124 Q37218017-D9DB4B9F-733C-47A0-B6FC-D9BA4CBFDF80 Q37536748-D29E1389-98CC-4CFC-A80F-7601AC10A1C6 Q37593021-97032299-CBBF-435C-AD17-18A3A2FD89C8 Q37615017-55BDE3ED-B2F7-4869-A2CC-1C6B830AB7F1 Q37968256-C74EC5F7-A4DE-43ED-A468-8469F83E144D Q38262816-93C48A28-B5BC-4CC4-8462-6EB1C50182AF Q38323440-FA102719-64F7-4C83-883E-AA885CB57110 Q38724639-63C54A5F-B7C1-4DB2-B8DB-B1CE861D90AE Q38806364-A1AD255F-5ABE-4C0D-8CDB-CA550116BE24 Q38815319-66070440-50E5-4200-B687-F02070A37839 Q38983836-C8AC3447-1A97-45ED-944A-BFB0C063FEE2 Q39179249-EC6804CA-618C-4DD1-90F5-EE6E780B1591 Q39237027-ACAB4F7A-2EFF-471A-A780-E3393A812BB7 Q39380409-911C8B4D-BFB1-423C-B4CF-728B6F80910F Q39439690-A9C46E08-89DB-4D39-B01E-A953D7A790C4 Q39511922-8344BC9F-7860-43F0-BC3B-C1E9962B3529 Q43069624-81332640-2E3C-44F4-A447-90AC4E64106F Q43147517-DE406113-8E0B-41AD-89E4-EC3093E2BFA3

P2860

A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression

http://www.wikidata.org/entity/Q34224640

description

2004 nî lūn-bûn

@nan

2004 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մարտին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

A potential oncogenic activity ...... in prostate cancer progression

@ast

A potential oncogenic activity ...... in prostate cancer progression

@en

A potential oncogenic activity ...... in prostate cancer progression

@nl

type

label

A potential oncogenic activity ...... in prostate cancer progression

@ast

A potential oncogenic activity ...... in prostate cancer progression

@en

A potential oncogenic activity ...... in prostate cancer progression

@nl

prefLabel

A potential oncogenic activity ...... in prostate cancer progression

@ast

A potential oncogenic activity ...... in prostate cancer progression

@en

A potential oncogenic activity ...... in prostate cancer progression

@nl

P1433

Q34224640-34D16565-7DE5-4050-8613-93A6E72C7803

P1476

Q34224640-A0B21AAA-161E-490B-99E6-E659B1FD88B6

P2093

Q34224640-1A8B4F9C-891B-40E2-AEBB-7B63E687C0F4

Q34224640-45EC8354-2E45-4C4A-8650-69122BEFBB12

Q34224640-B46FA335-3C89-437B-B634-9BABE3FF3DA4

Q34224640-BCE5E3A3-17DC-4197-AC8C-0BDA98C10BE6

Q34224640-E80DE64D-C184-4B28-9174-9D9BBEE83C56

Q34224640-F596A305-6765-4C8C-84BF-EC626128BC4A

Q34224640-F65FA0F7-FA26-417F-908E-42B3B4C1CF57

P2860

Q34224640-1D22AF08-EA84-485D-A9CF-09F0514A97B9

Q34224640-2599177A-B0EE-423E-98C3-89C9CC7CA1B1

Q34224640-26451B11-825A-4F3F-9E83-2D9D56834D59

Q34224640-28489BCD-7400-408F-BF4E-704C7A80898F

Q34224640-3C4933F4-650E-4D93-8AF8-8599A6F809E4

Q34224640-3E567341-2F46-4D77-8DFC-110893783138

Q34224640-48BF8915-90D4-4E22-830F-EF61B975A3B7

Q34224640-4CBF64EF-72DD-4C77-B9E9-A15407E181C6

Q34224640-57E360D6-A3ED-4E6A-8FDF-80C131FA1B14

Q34224640-5895A84F-67CA-4318-981B-2BB4F7BE1039

P304

Q34224640-F48B2FCE-D144-4233-A5EF-B14AD7E65C83

P31

Q34224640-B30C8461-A7AF-4D8C-999E-1921E82AEBC1

P356

Q34224640-8B4A7BDA-0E8F-414E-B082-BA4D434E0D4B

P407

Q34224640-A40231EC-059A-4124-8967-455CF7CC0F22

P433

Q34224640-EC4B0D85-1DAC-4BEA-B1FC-85270C65838E

P478

Q34224640-7A8F6E92-7EEE-49CE-B2CA-15E4D4307525

P50

Q34224640-83A70533-7BDD-4EBB-B33B-09910EE67597

P577

Q34224640-254485F8-17A3-44A6-AFC7-A04BA2141CE1

P698

Q34224640-E9A060C8-EC0F-4065-B24F-AA9767321FB5

P932

Q34224640-CE4D137E-CBE6-48EB-ACC3-F8EC4B331993

P356

0008-5472.CAN-03-3047

P1433

Cancer Research

P1476

A potential oncogenic activity ...... in prostate cancer progression

@en

P2093

Carolyn V Ustach

http://www.w3.org/2001/XMLSchema#string

Hyeong-Reh Choi Kim

http://www.w3.org/2001/XMLSchema#string

Lucia Schuger

http://www.w3.org/2001/XMLSchema#string

Marcus E Taube

http://www.w3.org/2001/XMLSchema#string

Michael L Cher

http://www.w3.org/2001/XMLSchema#string

Newton J Hurst

http://www.w3.org/2001/XMLSchema#string

Sunita Bhagat

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of action and in vivo role of platelet-derived growth factor

PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor

Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains

PDGF-D, a new protease-activated growth factor

Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes.

Structure and functions of the interaction domains of C1r and C1s: keystones of the architecture of the C1 complex.

Hormone-refractory prostate cancer: an evolving standard of care.

PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor.

Chromosomal location, exon structure, and vascular expression patterns of the human PDGFC and PDGFD genes.

Complement components C1r/C1s, bone morphogenic protein 1 and Xenopus laevis developmentally regulated protein UVS.2 share common repeats.

P304

1722-1729

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-03-3047

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

R. Daniel Bonfil

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14996732

http://www.w3.org/2001/XMLSchema#string

P932

4171134

http://www.w3.org/2001/XMLSchema#string